Gratus Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
1,813
-1
-0.1% -$1.02K 0.28% 34
2026
Q1
$1.67M Buy
1,814
+14
+0.8% +$14.2K 0.24% 34
2025
Q4
$1.93M Buy
1,800
+69
+4% +$66K 0.27% 32
2025
Q3
$1.32M Sell
1,731
-6
-0.3% -$4.46K 0.19% 48
2025
Q2
$1.35M Buy
1,737
+89
+5% +$69.2K 0.21% 45
2025
Q1
$1.36M Sell
1,648
-26
-2% -$21.6K 0.22% 40
2024
Q4
$1.29M Sell
1,674
-47
-3% -$38.9K 0.21% 46
2024
Q3
$1.55M Buy
1,721
+434
+34% +$390K 0.25% 43
2024
Q2
$1.1M Buy
1,287
+114
+10% +$91.2K 0.19% 47
2024
Q1
$875K Sell
1,173
-208
-15% -$148K 0.16% 62
2023
Q4
$805K Buy
+1,381
New +$806K 0.16% 63

Other funds holding LLY

Gratus Wealth Advisors's LLY Position: Q2 2026 in Review

Gratus Wealth Advisors reduced its Eli Lilly (LLY) stake by 0.06% in Q2 2026, selling an estimated $1.02K and leaving 1,813 shares worth $2.17M. The position accounts for 0.28% of the portfolio, ranked #34.

Gratus Wealth Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gratus Wealth Advisors held 1,813 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • Gratus Wealth Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.28% of Gratus Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • Gratus Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gratus Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.